Core Insights - Tectonic Therapeutic, Inc. is a clinical-stage biotechnology company focused on developing therapeutic proteins and antibodies targeting G-protein coupled receptors (GPCRs) [4] Upcoming Conferences - Tectonic management will participate in the Piper Sandler 37th Annual Healthcare Conference on December 2, 2025, at 3:30 PM EST in New York, NY, in a fireside chat format [2] - The company will also attend the Evercore 8th Annual Healthcare Conference on December 3, 2025, in Miami, FL, conducting investor meetings [2][3] Company Overview - Tectonic utilizes its proprietary GEODe™ technology platform to enhance GPCR-targeted drug discovery, aiming to develop biologic medicines for areas with significant unmet medical needs [4] - The company is headquartered in Watertown, Massachusetts, and focuses on improving patient quality of life through innovative therapeutic options [4]
Tectonic Therapeutic to Participate in December Investor Conferences